Abstract: Herbal extracts composition suitable for weight management in mammals is disclosed. The composition comprises a mixture of Garcinia extract, Green tea extract, Green coffee extract and Banaba extract. The method of reducing weight, and treating diabetes in mammals involve oral administration of the composition. The invention further relates to a method of producing and standardizing the individual extract useful for human health.
Abstract: A proteineous component isolated from plant chromatin, after dissociation of the same, as an antimicrobial agent, the proteineous component having an apparent molecular weight between 10 and 20 kD. The proteineous plant component is produced by means of a method comprising the steps of homogenizing a plant material in order to expose its plant chromatin, dissociating the plant chromatin with a dissociating agent under hydrophobic conditions, and separating the dissociated plant chromatin into individual fractions, one comprising the proteineous plant component, by means of a hydrophobic interaction separation procedure.
Abstract: A method of treating or ameliorating an indication of mucosal or adjacent tissue comprising periodically applying to mucosa at or adjacent to disease affected tissue a rinse comprising: an effective amount of appropriate composition of herbal bioactive comprising active(s) of one or more of Sambucus nigra, Centella asiatica or Echinacea purpurea; an antimicrobially effective amount of a quaternary ammonium surfactant; and optionally a polymer or mixture of polymers effective to coat said tissue and entrap said extract(s).
Type:
Grant
Filed:
July 20, 2007
Date of Patent:
December 13, 2011
Assignee:
IZUN Pharmaceuticals Corporation
Inventors:
Zvi G. Loewy, William Zev Levine, Aron J. Saffer
Abstract: An invention relates to an extract of Chlorella sorokiniana, which contains myristic acid, palmitic acid, palmitoleic acid, oleic acid, linoleic acid, linolenic acid, and stearic acid. Also related is use of this extract to treat diabetes, obesity, and dyslipidaemia.
Type:
Grant
Filed:
October 16, 2008
Date of Patent:
November 1, 2011
Assignee:
International Chlorella Co., Ltd.
Inventors:
Hsing-Pang Hsieh, Tsu-An Hsu, Yu-Sheng Chao, Yu-Cheng Chou, Shun Te Wang
Abstract: A method of treating CD33+ acute and chronic myeloid leukemia in animals including humans, using fraction nos. 1 and 9 obtained from water:methanol fraction by column chromatography, with ratio of water and methanol ranging between 1:5 to 5:1, wherein said water:methanol fraction is obtained from the polar extract of Piper betel by HPLC, with retention time of 3.6 and 24.0 minutes respectively, with said fractions used both individually, and in combination.
Type:
Grant
Filed:
November 23, 2009
Date of Patent:
October 4, 2011
Assignee:
Council of Scientific and Industrial Research
Abstract: A cosmetic composition consists of a combination of peptides that regenerate the dermal matrix and a rapid acting muscle relaxant derived from the extract of the plant, Acmella oleracea. By limiting cutaneous deformation caused by the contraction of facial muscles the extract increases the efficiency of the peptides in reducing expression lines.
Abstract: The invention provides saponin mixtures and compounds which are isolated from the species Acacia victoriae and methods for their use. These compounds may contain a triterpene moiety, such as acacic or oleanolic acid, to which oligosaccharides and monoterpenoid moieties are attached. The mixtures and compounds have properties related to the regulation of apoptosis and cytotoxicity of cells and exhibit potent anti-tumor effects against a variety of tumor cells.
Type:
Grant
Filed:
January 15, 2010
Date of Patent:
July 26, 2011
Assignee:
Research Development Foundation
Inventors:
Charles J. Arntzen, Mary E. Blake, Jordan U. Gutterman, Joseph J. Hoffmann, Gamini S. Jayatilake, David T. Bailey
Abstract: An adhesive solid therapeutic composition containing an active ingredient which is an extract of a plant selected from the group consisting of Sambucus nigra, Centella asiatica and Echinacea purpurea, or mixtures thereof and excipients, said excipients comprising (i) a bulk ingredient (ii) an adhesive polymer of acrylic acid and (iii) polyyinylpyrrolidone.
Abstract: Pregnane glycoside or a Caralluma extract including the pregnane glycoside of the present invention can be used for medical purposes and as food additives, such as a treatment of obesity, a reduction of blood glucose, a reduction of blood pressure, a reduction in hip, waist and arm circumferences, a reduction of fat, increase of BMR, a decrease of BMI, an increase of lean body mass, an appetite-suppression and a reduction/elimination of joint pain, anti-aging, a treatment for falling sex drive, the treatment for impotency and an erectile dysfunction, and an enhancement of energy levels.
Abstract: A pharmaceutical composition comprising an analgesic or analgesic combination and a stool softener is disclosed. The analgesic is selected from morphine, meperidine, fentanyl, hydromorphone, oxymorphone, oxycodone, hydrocodone, methadone, propoxyphene, pentazocine, levorphanol, codeine, acetaminophen and combinations of these analgesics. The composition is formulated for oral administration as a liquid or solid dosage form for immediate, slow, delayed or sustained-release characteristics.
Abstract: Compositions for supporting healthy memory and optimizing mental energy and methods for improving, preventing, and treating mental disorders or deterioration. The compositions of the invention can be formulated as nutritional or dietary supplements.
Abstract: A composition including one or more of elecampane rhizome (Inula sp.), fennel fruit (Foeniculum sp.), juniper berry (Juniperus sp.), licorice root (Glycyrrhiza sp.), oregano herb (Oreganum sp.), marigold flowers (Calendula sp.), rose hips (Rosa sp.), and thyme (Thymus sp.), or an extract thereof. The composition is useful for treating infectious diseases, for example viral and microbial infections, and for reducing the toxic effects of chemotherapeutic agents.
Abstract: A cosmetic composition comprises a coffee cherry preparation, and most preferably an extract from a sub-ripe quick-dried coffee cherry. Particularly contemplated cosmetic compositions are formulated as a shampoo, lotion, cream, balm, or ointment, and will have at least one of an antioxidant effect, an anti-inflammatory effect, a UV-protective effect, an antimutagenic effect, a chemoprotective effect, a scar reducing effect, a skin-lightening effect, a moisturizing effect, a wrinkle reduction effect, and an antibacterial effect.
Abstract: A method for treating psoriasis by providing a pharmaceutical composition containing at least Ganoderma lucidum extract and administering a therapeutically effective amount of the composition to a patient in need thereof. Also disclosed is a method for treating psoriasis by first purifying Ganoderma lucidum extract into at least one fraction, then providing a pharmaceutical composition comprising at least one of the Ganoderma lucidum fractions, and administering a therapeutically effective amount of the composition to a patient in need thereof. A method for alleviating symptoms of psoriasis is disclosed. The symptoms of psoriasis are alleviated by providing a pharmaceutical composition containing at least Ganoderma lucidum extract and administering an amount of the composition effective to increase at least one of an IL-10 and IL-1Ra expression, whereby the symptoms of psoriasis are ameliorated.
Type:
Grant
Filed:
August 29, 2008
Date of Patent:
May 24, 2011
Assignees:
Wyntek Corporation, Academia Sinica
Inventors:
Tseng-Rong Tu, Chia-Feng Li, Sung-Hsieh Su, Chi-Huey Wong, Eugene Fan
Abstract: The invention provides a solid, self-bioadhesive composition for topical application that adheres to the oral mucosal tissue comprising a therapeutically effective amount of at least one herbal or homeopathic active agent; and a pharmaceutically acceptable solid bioadhesive carrier in an amount from about 40 to 99 percent based on the weight of the whole composition.
Type:
Grant
Filed:
February 27, 2002
Date of Patent:
May 17, 2011
Assignee:
Axiomedic Ltd
Inventors:
Avraham J. Domb, Joseph Simcha Wolnerman
Abstract: Homeopathic formulations (a) comprising tinctures and/or diluted extracts preferably subjected to potentization of at least 8 or 9 herbs selected from Bellis Perennis, Calendula Officinalis, Hamamelis Virginiana, Arnica Montana, Hypericum Perforatum, Aconitum Napellus, Ledum Palustre, Bryonia Alba and Ruta Graveolens; or (b) consisting of, as active ingredients, tinctures and/or diluted extracts subjected to potentization of 5, 6 or 7 herbs selected from Bellis Perennis, Calendula Officinalis, Hamamelis Virginiana, Arnica Montana, Hypericum Perforatum, Aconitum Napellus, Ledum Palustre, Bryonia Alba and Ruta Graveolens. The potentized homeopathics are in a penetrating base, preferably clear gel base. The homeopathic formulations are highly effective in treating or relieving pain and inflammation. Also, a method of treating or relieving pain and inflammation by administering any of the homeopathic formulations of the invention to a subject, preferably a subject in need of such treatment or relief.
Abstract: Drugs and cosmetics which are highly safe, and which are effective in preventing, improving, or treating various pathological conditions caused by estrogen depletion are provided. Provided are aromatase activators containing at least one member selected from plants such as Labiatae sps. including Isodon, Scutellaria (huangcen), Schizonepeta (jingjie), sage, lavender, Lamium album, and thyme, an extract thereof; yeast extract; silk protein extract; milk protein; trehalose; natto extract; royal jelly; oryza oil; hydrolyzated wheat extract; shea butter; and rice fermentation extract.
Abstract: A process for the preparation of Labisia pumila extract from Labisia pumila plant material and to obtain an optimized and reproducible chemical profile by high performance liquid chromatography.
Type:
Grant
Filed:
January 12, 2006
Date of Patent:
February 1, 2011
Assignee:
The Government of Malaysia as represented by the Ministry of Science, Technology and Innovation
Inventors:
Mashitah Mohd. Yusoff, Wan Nazaimoon Wan Mohamud
Abstract: The provision of a GM-CSF increasing agent or a TNF-? modulator, which is a composition comprising Cucurbita moschata, Carthamus tinctorius, Plantago asiatica and Lonicera japonica; or a health food, nutritional supplementary food, or the like for increase of GM-CSF, and the prevention of Crohn's disease and the like, and the prognosis thereof, which comprises Cucurbita moschata, Carthamus tinctorius, Plantago asiatica and Lonicera japonica.